Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?

Critical Reviews in Oncology/Hematology

Volumn 75, Issue 2, 2010, Pages 138-150

  Protiere C ^a,b   Viens, Patrice ^b,c   Rousseau, Frédérique ^c   Moatti, Jean Paul ^a,b  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSTITUT PAOLI CALMETTES   (France)

Author keywords

Breast cancer; Chemotherapy prescription; Elderly; Medical decision making; Physicians' behavior

Indexed keywords

ANTINEOPLASTIC AGENT;

AGING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; COMORBIDITY; DEMOGRAPHY; ELDERLY CARE; EMPATHY; HEALTH CARE ACCESS; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL SPECIALIST; PATIENT ASSESSMENT; PATIENT CARE; PATIENT PARTICIPATION; PHYSICIAN ATTITUDE; PROFESSIONAL KNOWLEDGE; REVIEW; AGED; ALGORITHM; BREAST NEOPLASMS; CLINICAL PRACTICE; DECISION MAKING; EVALUATION STUDY; FEMALE; FRANCE; GERIATRIC ASSESSMENT; HEALTH PERSONNEL ATTITUDE; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREJUDICE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; DECISION MAKING; EMPATHY; FEMALE; FRANCE; GERIATRIC ASSESSMENT; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PHYSICIAN'S PRACTICE PATTERNS; PREJUDICE; QUESTIONNAIRES;

EID: 77954789337     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2009.09.007     Document Type: Review

References (42)

1. Gajdos C., Tartter P.I., Bleiweiss I.J., Lopchinsky R.A., Bernstein J.L. The consequence of undertreating breast cancer in the elderly. Journal of the American College of Surgeons 2001, 192(6):698-707.
2. Firvida J.L., Vinolas N., Munoz M., et al. Age: a critical factor in cancer management. A prospective comparative study of 400 patients. Age and Ageing 1999, 28(2):103-105.
3. Monfardini S. Opening lecture. 3rd SIOG meeting. 7th international conference on geriatric oncology-cancer in the elderly 2002.
4. Townsley C., Pond G.R., Peloza B., et al. Analysis of treatment practices for elderly cancer patients in Ontario, Canada. Journal of Clinical Oncology 2005, 23(16):3802-3810.
5. Perkins P., Cooksley C.D., Singletary S.E., Cox J.D. Differences in breast cancer treatment and survival between older and younger women. The Breast Journal 1999, 5(3):156-161.
6. Hurria A., Naeim A., Elkin E., et al. Adjuvant treatment recommendations in older women with breast cancer-a survey of oncologists. Critical Reviews in Oncology/Hematology 2006.
7. Evans J.G. Introduction. Oxford textbook of geriatric medicine 2000, Oxford University Press. 2nd ed. W. Evans, B. Miche, Wilcock (Eds.).
8. Balducci L., Extermann M., Carreca I. Management of breast cancer in the older woman. Cancer Control 2001, 8(5):431-441.
9. Truong P.T., Bernstein V., Wai E., Chua B., Speers C., Olivotto I.A. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. International Journal of Radiation Oncology Biology Physics 2002, 54(3):794-803.
10. Aapro M.S. The frail are not always elderly. Journal of Clinical Oncology 2005, 23(10):2121-2122.
11. Velanovich V., Gabel M., Walker E.M., et al. Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. Journal of the American College of Surgeons 2002, 194(1):8-13.
12. Yancik R., Ganz P.A., Varricchio C.G., Conley B. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. Journal of Clinical Oncology 2001, 19(4):1147-1151.
13. Castiglione M., Gelber R.D., Goldhirsch A. Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. Journal of Clinical Oncology 1990, 8(3):519-526. International Breast Cancer Study Group.
14. Cummings F.J., Gray R.E., Tormey D.C., et al. Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. Journal of Clinical Oncology 1993, 11(1):29-35.
15. Guadagnoli E., Shapiro C., Gurwitz J.H., et al. Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer. Journal of Clinical Oncology 1997, 15(6):2338-2344.
16. Bouchardy C., Rapiti E., Fioretta G., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. Journal of Clinical Oncology 2003, 21(19):3580-3587.
17. Popescu R.A., Norman A., Ross P.J., Parikh B., Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. Journal of Clinical Oncology 1999, 17(8):2412-2418.
18. Crivellari D., Aapro M., Leonard R., et al. Breast cancer in the elderly. Journal of Clinical Oncology 2007, 25(14):1882-1890.
19. Crivellari D., Bonetti M., Castiglione-Gertsch M., et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the international breast cancer study group trial VII. Journal of Clinical Oncology 2000, 18(7):1412-1422.
20. Pritchard K.I., Paterson A.H., Fine S., et al. Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology 1997, 15(6):2302-2311.
21. Yood M.U., Owusu C., Buist D.S., et al. Mortality impact of less-than-standard therapy in older breast cancer patients. Journal of the American College of Surgeons 2008, 206(1):66-75.
22. Enger S.M., Thwin S.S., Buist D.S., et al. Breast cancer treatment of older women in integrated health care settings. Journal of Clinical Oncology 2006, 24(27):4377-4383.
23. Hershman D.L., Buono D., McBride R.B., et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. Journal of the National Cancer Institute 2008, 100(3):199-206.
24. Silliman R.A., Demissie S., Troyan S.L. The care of older women with early-stage breast cancer: what is the role of surgeon gender?. Medical Care 1999, 37(10):1057-1067.
25. Mandelblatt J.S., Berg C.D., Meropol N.J., et al. Measuring and predicting surgeons' practice styles for breast cancer treatment in older women. Medical Care 2001, 39(3):228-242.
26. Ellis R.P., McGuire T.G. Hospital response to prospective payment: moral hazard, selection, and practice-style effects. Journal of Health Economics 1996, 15(3):257-277.
27. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000, 5(3):224-237.
28. Chen H., Cantor A., Meyer J., et al. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 2003, 97(4):1107-1114.
29. Extermann M., Overcash J., Lyman G.H., Parr J., Balducci L. Comorbidity and functional status are independent in older cancer patients. Journal of Clinical Oncology 1998, 16(4):1582-1587.
30. Kohne C.H., Folprecht G., Goldberg R.M., Mitry E., Rougier P. Chemotherapy in elderly patients with colorectal cancer. Oncologist 2008, 13(4):390-402.
31. Jones T.V., Gerrity M.S., Earp J. Written case simulations: do they predict physicians' behavior?. Journal of Clinical Epidemiology 1990, 43(8):805-815.
32. Protiere C., Moumjid N., Le Corroller Soriano A.G., Malavolti L., Moatti J.P. Patients' information seeking behavior in cancer: is there more than a communication problem with the medical team? 2008, EACH, Oslo, Norway.
33. Du X.L., Key C.R., Osborne C., Mahnken J.D., Goodwin J.S. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Annals of Internal Medicine 2003, 138(2):90-97.
34. Fisher B., Redmond C., Legault-Poisson S., et al. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. Journal of Clinical Oncology 1990, 8(6):1005-1018.
35. Luchini S., Protière C., Moatti J.P. Evaluating several willingness to pay in a single contingent evaluation: application to health care. Health Economics 2003, 12(1):51-64.
36. Protière C., Donaldson C., Moatti J.P., Luchini S., Shackley P. The impact of information on non-health attributes on willingness to pay for multiple health care programmes. Social Science & Medicine 2004, 58(7):1257-1269.
37. Bailey C., Corner J., Addington-Hall J., Kumar D., Nelson M., Haviland J. Treatment decisions in older patients with colorectal cancer: the role of age and multidimensional function. European Journal of Cancer Care 2003, 12(3):257-262.
38. Bernardi D., Errante D., Galligioni E., et al. Treatment of breast cancer in older women. Acta Oncology 2007, 1-13.
39. Gosney M. Contribution of the geriatrician to the management of cancer in older patients. European Journal of Cancer 2007, 43(15):2153-2160.
40. Maas H.A., Janssen-Heijnen M.L., Olde Rikkert M.G., Machteld Wymenga A.N. Comprehensive geriatric assessment and its clinical impact in oncology. European Journal of Cancer 2007, 43(15):2161-2169.
41. Mandelblatt J.S., Edge S.B., Meropol N.J., et al. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. Journal of Clinical Oncology 2003, 21(5):855-863.
42. Elkin E.B., Kim S.H.M., Casper E.S., Kissane D.W., Schrag D. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. Journal of Clinical Oncology 2007, 25(33):5275-5280.